Vonoprazan: first global approval

Drugs
Karly P Garnock-Jones

Abstract

Vonoprazan (Takecab(®)) is an orally bioavailable potassium-competitive acid blocker (P-CAB) being developed by Takeda for the treatment and prevention of acid-related diseases. The drug is approved in Japan for the treatment of acid-related diseases, including erosive oesophagitis, gastric ulcer, duodenal ulcer, peptic ulcer, gastro-oesophageal reflux, reflux oesophagitis and Helicobacter pylori eradication. Phase III development is underway for the prevention of recurrence of duodenal and gastric ulcer in patients receiving aspirin or NSAID therapy. Phase I development was conducted in the UK for gastro-oesophageal reflux; however, no further development has been reported. This article summarizes the milestones in the development of vonoprazan leading to this first approval for acid-related diseases.

Citations

Oct 2, 2015·Alimentary Pharmacology & Therapeutics·D R ScottG Sachs
Apr 23, 2016·Gastroenterology·Carlo A FalloneJohn K Marshall
Aug 6, 2016·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Daisuke MaruokaOsamu Yokosuka
Oct 28, 2016·Gut and Liver·Jaeyong HanTong Wang
Nov 3, 2016·Therapeutic Advances in Gastroenterology·Yuko AkazawaYutaka Fukuda
Mar 8, 2017·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Izumi TsuchiyaMotoyoshi Izumi
Jun 29, 2017·Expert Opinion on Pharmacotherapy·Irene MartinucciEdoardo Savarino
Jul 5, 2017·Journal of Neurogastroenterology and Motility·Hidekazu Suzuki
Apr 17, 2018·Journal of Applied Toxicology : JAT·Tianyi LiXuejun He
Sep 14, 2018·Expert Review of Anti-infective Therapy·Amin Talebi Bezmin Abadi, Johannes G Kusters
Mar 22, 2019·The Journal of Pharmacology and Experimental Therapeutics·Dong Kyu KimShin-Young Ryu
May 3, 2019·Current Opinion in Gastroenterology·Carmelo Scarpignato, Richard H Hunt
Jul 3, 2020·The Keio Journal of Medicine·Hidekazu Suzuki
Sep 17, 2020·Annals of the New York Academy of Sciences·Carmelo ScarpignatoRichard H Hunt
Dec 29, 2017·Digestive Diseases and Sciences·Xiaoxiao YangYan-Qing Li
Aug 9, 2018·Journal of Clinical Biochemistry and Nutrition·Akinori Yanaka
Apr 27, 2019·Frontiers in Pharmacology·Amin Talebi Bezmin Abadi, Enzo Ierardi
Mar 3, 2020·Frontiers in Pharmacology·Yiran WangQingfeng Luo
Oct 27, 2018·Current Treatment Options in Gastroenterology·Richard H Hunt, Carmelo Scarpignato
Jun 26, 2020·Drug Design, Development and Therapy·Jiquan ShenBin Liu
Oct 2, 2020·Pharmaceuticals·Muhammad MiftahussururYoshio Yamaoka
Jan 1, 2019·World Journal of Gastrointestinal Pharmacology and Therapeutics·Prashanth RawlaVinaya Gaduputi
Jan 18, 2018·Gastroenterology·David Y Graham, Maria Pina Dore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved